Upholding the EU's Commitment to 'Animal Testing as a Last Resort' Under REACH Requires a Paradigm Shift in How We Assess Chemical Safety to Close the Gap Between Regulatory Testing and Modern Safety Science.

REACH alternatives animal testing chemical safety new approach methodologies next generation risk assessment product safety regulatory testing safety science

Journal

Alternatives to laboratory animals : ATLA
ISSN: 0261-1929
Titre abrégé: Altern Lab Anim
Pays: England
ID NLM: 8110074

Informations de publication

Date de publication:
Jul 2021
Historique:
pubmed: 1 9 2021
medline: 15 12 2021
entrez: 31 8 2021
Statut: ppublish

Résumé

Animal use for testing chemicals under REACH continues to increase, despite advances in non-animal safety science during the past 15 years. The application of modern science and technology, and the use of 'next generation' weight-of-evidence assessment approaches, are embedded in EU guidance for establishing the safety of cosmetics and foods - and of the ingredients used in these products. However, this is still not the case for the regulation of chemicals. Under the new Chemicals Strategy for Sustainability, thought leaders in human health and environmental protection are calling on the European Commission to quickly embrace the benefits of modern and innovative non-animal safety science, in place of outdated animal testing, if the EU is to be a leader in safe and sustainable innovation under the European Green Deal transformational change ambitions. The European Commission also needs to enable companies to meet their legal obligation to only conduct animal testing as a last resort, by providing a more flexible, science-based and consistent regulatory framework for assuring chemical safety, which supports the integration of data from different sources. We are at a tipping point for closing the gap between regulatory chemicals testing and modern safety science. It is time to join forces, across policy makers, scientists, regulators and lawyers, to lead the paradigm shift needed to deliver what EU citizens want - namely, chemicals and products that are safe and sustainable, without resorting to animal testing.

Identifiants

pubmed: 34461762
doi: 10.1177/02611929211040824
doi:

Substances chimiques

Cosmetics 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122-132

Auteurs

Julia Fentem (J)

Unilever Safety & Environmental Assurance Centre (SEAC), 3099Unilever Plc, Bedfordshire, UK.

Ian Malcomber (I)

Unilever Safety & Environmental Assurance Centre (SEAC), 3099Unilever Plc, Bedfordshire, UK.

Gavin Maxwell (G)

Unilever Safety & Environmental Assurance Centre (SEAC), 3099Unilever Plc, Bedfordshire, UK.

Carl Westmoreland (C)

Unilever Safety & Environmental Assurance Centre (SEAC), 3099Unilever Plc, Bedfordshire, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH